Literature DB >> 12891375

Genetic information and life insurance: a 'real' risk?

Yann Joly1, Bartha M Knoppers, Béatrice Godard.   

Abstract

Public concern about genetic discrimination, particularly access to insurance following genetic testing, has been reported in the literature. This paper aims to separate myths from realities regarding genetic discrimination in life insurance and to underline the positive aspects of allowing insurers access to relevant genetic information for underwriting purposes. We present a review of the literature pertinent to discrimination in life insurance and a comparative analysis of industries guidelines. There are few reported cases in the literature of validated genetic discrimination. However, the benefits to be gained by allowing insurers access to relevant genetic data could justify fostering a more active role in the use of genetic information by insurance companies.

Keywords:  Genetics and Reproduction

Mesh:

Year:  2003        PMID: 12891375     DOI: 10.1038/sj.ejhg.5200998

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  4 in total

1.  Unjustified discrimination: is the moratorium on the use of genetic test results by insurers a contradiction in terms?

Authors:  Ruth Wilkinson
Journal:  Health Care Anal       Date:  2010-09

2.  Access to health insurance: experiences and attitudes of those with genetic versus non-genetic medical conditions.

Authors:  Nancy E Kass; Amy M Medley; Marvin R Natowicz; Sara Chandros Hull; Ruth R Faden; Laura Plantinga; Lawrence O Gostin
Journal:  Am J Med Genet A       Date:  2007-04-01       Impact factor: 2.802

3.  Counsellee's experience of cancer genetic counselling with pedigrees that automatically incorporate genealogical and cancer database information.

Authors:  Vigdis Stefansdottir; Oskar Th Johannsson; Heather Skirton; Jon J Jonsson
Journal:  J Community Genet       Date:  2016-07-02

4.  Policy recommendations for addressing privacy challenges associated with cell-based research and interventions.

Authors:  Ubaka Ogbogu; Sarah Burningham; Adam Ollenberger; Kathryn Calder; Li Du; Khaled El Emam; Robyn Hyde-Lay; Rosario Isasi; Yann Joly; Ian Kerr; Bradley Malin; Michael McDonald; Steven Penney; Gayle Piat; Denis-Claude Roy; Jeremy Sugarman; Suzanne Vercauteren; Griet Verhenneman; Lori West; Timothy Caulfield
Journal:  BMC Med Ethics       Date:  2014-02-03       Impact factor: 2.652

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.